Aims/hypothesis. The estimation of effect size in clinical trials commonly disregards recurrent outcomes. We investigated the effectiveness of a complex ...
Unfortunately this is not a free paper. However, you can see the first pages by the publishers web-page. Please go to: http://link.springer.com/article/10.1007%2Fs00125-014-3204-1 Look Inside Get Access
Diabetologia June 2014, Volume 57, Issue 6, pp 1119-1123 Date: 06 Mar 2014 The effectiveness of structured personal care of type 2 diabetes on recurrent outcomes: a 19 year follow-up of the study Diabetes Care in General Practice (DCGP)
Hanna Lundström, Volkert Siersma, Anni B. Sternhagen Nielsen, John Brodersen, Susanne Reventlow, Per K. Andersen, Niels de Fine Olivarius Buy now
$39.95 / €34.95 / £29.95 * Rent the article at a discount Rent now * Final gross prices may vary according to local VAT. Get Access Abstract Aims/hypothesis The estimation of effect size in clinical trials commonly disregards recurrent outcomes. We investigated the effectiveness of a complex intervention on recurrent outcomes in patients with type 2 diabetes. Methods In the Diabetes Care in General Practice (DCGP) randomised controlled trial, 1,381 patients newly diagnosed with type 2 diabetes were randomised to 6 years of structured personal care or routine care (ClinicalTrials.gov NCT01074762). The trial had 19 years of registry-based follow-up and was analysed with Cox regression models. Repeated occurrences in the same patient of outcomes (any diabetes-related endpoint, myocardial infarction [MI], stroke, peripheral vascular disease and microvascular disease) were accounted for with the Wei, Lin and Weissfeld method. Results As previously shown, the intervention reduced the rates of first occurrence of both MI and any diabetes-related endpoint. However, for all outcomes, the HR for a second event showed a statistically non-significant tendency to be increased. We estimated a combined HR for all marginal failure times, regardless of whether they were first, second or later events. This showed that the intervention had no effect on the rate of any of the outcomes, including MI (HR 0.89, 95% CI 0.76, 1.05) and any diabetes-related endpoint (HR 0.98, 95% CI 0.87, 1.09). Conclusions/interpretation In the DCGP study, a smaller proportion of patients who received structured care experienced a first occurrence of MI or any diabetes-related endpoint compared with patients who received routine care. However, the patients who received structured care tended to experience more recurrent outcomes, so the total outcome rate was not affected by the intervention.
